Circulating exo-miRNA-27a-5p is a novel biomarker of the tofacitinib treatment response in rheumatoid arthritis
This study suggests that circulating exo-miR-27a-5p is a novel non-invasive biomarker to monitor the response to tofacitinib treatment.
Authors
- F. Liu
- Quan Liao (ORCID: https://orcid.org/0000-0003-1324-6213)
- Jiwei Zhao (ORCID: https://orcid.org/0000-0002-9298-9412)
- Jijia Sun (ORCID: https://orcid.org/0000-0001-5068-4357)
- Tao Zhu (ORCID: https://orcid.org/0000-0001-9614-3476)
Institutions
- Nanjing Traditional Chinese Medicine Hospital (CN)
- Jiangsu Vocational College of Medicine (CN)
Publication Details
- Journal
- BMC Rheumatology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1186/s41927-025-00502-1
- Citations
- 2
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Shanghai University of Traditional Chinese Medicine